| 1 | Primary Melanoma of the Urinary Bladder: Clinical, Histopathologic, and Comprehensive Molecular Analysis of a Rare Tumor | 0.6 | 2 | Citations (PDF) |
| 2 | Congenital melanocytic naevi initiated by BRAF fusion oncogene with firmness, pruritus and desmoplastic stroma | 0.9 | 8 | Citations (PDF) |
| 3 | Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK) | 1.9 | 11 | Citations (PDF) |
| 4 | Distinct senescence mechanisms restrain progression of dysplastic nevi | 2.4 | 6 | Citations (PDF) |
| 5 | Amplification of Mutant NRAS in Melanocytic Tumors With Features of Spitz Tumors | 3.8 | 8 | Citations (PDF) |
| 6 | The genetic evolution of acral melanoma | 10.8 | 34 | Citations (PDF) |
| 7 | Spectrum of Melanocytic Tumors Harboring BRAF Gene Fusions: 58 Cases With Histomorphologic and Genetic Correlations | 3.8 | 27 | Citations (PDF) |
| 8 | Histologic and Genetic Features of 51 Melanocytic Neoplasms With Protein Kinase C Fusion Genes | 3.8 | 27 | Citations (PDF) |
| 9 | Tracing cancer evolution and heterogeneity using Hi-C | 10.8 | 15 | Citations (PDF) |
| 10 | Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes | 5.9 | 39 | Citations (PDF) |
| 11 | Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations | 5.8 | 17 | Citations (PDF) |
| 12 | Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome | 1.9 | 15 | Citations (PDF) |
| 13 | Melanoma pathology: new approaches and classification* | 0.9 | 53 | Citations (PDF) |
| 14 | MicroRNA Ratios Distinguish Melanomas from Nevi | 1.5 | 49 | Citations (PDF) |
| 15 | Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer | 4.5 | 93 | Citations (PDF) |
| 16 | Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features | 5.8 | 75 | Citations (PDF) |
| 17 | Spitz melanoma is a distinct subset of spitzoid melanoma | 3.8 | 103 | Citations (PDF) |
| 18 | The genomic landscapes of individual melanocytes from human skin | 30.7 | 128 | Citations (PDF) |
| 19 | Eruptive Spitz nevus, a striking example of benign metastasis | 2.7 | 18 | Citations (PDF) |
| 20 | Pervasive chromosomal instability and karyotype order in tumour evolution | 30.7 | 358 | Citations (PDF) |
| 21 | The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway | 1.7 | 463 | Citations (PDF) |
| 22 | The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma | 2.6 | 32 | Citations (PDF) |
| 23 | Functional characterization of uveal melanoma oncogenes | 5.2 | 65 | Citations (PDF) |
| 24 | Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes | 3.8 | 40 | Citations (PDF) |
| 25 | The genetic landscape of anaplastic pleomorphic xanthoastrocytoma | 3.0 | 122 | Citations (PDF) |
| 26 | Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets | 10.8 | 304 | Citations (PDF) |
| 27 | The genetic evolution of metastatic uveal melanoma | 14.1 | 198 | Citations (PDF) |
| 28 | Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses | 4.4 | 96 | Citations (PDF) |
| 29 | Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma | 10.8 | 137 | Citations (PDF) |
| 30 | Targeted Genomic Profiling of Acral Melanoma | 3.2 | 177 | Citations (PDF) |
| 31 | Next-Generation Sequencing of Uveal Melanoma for Detection of Genetic Alterations Predicting Metastasis | 1.6 | 58 | Citations (PDF) |
| 32 | Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations | 3.2 | 11 | Citations (PDF) |
| 33 | Ewing sarcoma in a child with neurofibromatosis type 1 | 0.8 | 1 | Citations (PDF) |
| 34 | Filigree-like Rete Ridges, Lobulated Nests, Rosette-like Structures, and Exaggerated Maturation Characterize Spitz Tumors With NTRK1 Fusion | 2.3 | 65 | Citations (PDF) |
| 35 | The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma | 1.9 | 12 | Citations (PDF) |
| 36 | Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations | 3.8 | 59 | Citations (PDF) |
| 37 | A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle | 10.8 | 77 | Citations (PDF) |
| 38 | Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway | 5.8 | 79 | Citations (PDF) |
| 39 | Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation | 5.8 | 17 | Citations (PDF) |
| 40 | Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts | 3.3 | 18 | Citations (PDF) |
| 41 | Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation | 28.4 | 140 | Citations (PDF) |
| 42 | Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution | 28.4 | 214 | Citations (PDF) |
| 43 | Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile | 5.8 | 66 | Citations (PDF) |
| 44 | The genetic landscape of ganglioglioma | 3.3 | 188 | Citations (PDF) |
| 45 | Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42 | 3.8 | 103 | Citations (PDF) |
| 46 | The genetic landscape of gliomas arising after therapeutic radiation | 5.8 | 86 | Citations (PDF) |
| 47 | Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy | 0.9 | 168 | Citations (PDF) |
| 48 | RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma | 28.4 | 160 | Citations (PDF) |
| 49 | Multiple Merkel cell carcinomas: Late metastasis or multiple primary tumors? A molecular study | 0.8 | 10 | Citations (PDF) |
| 50 | Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution | 2.7 | 31 | Citations (PDF) |
| 51 | Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi | 10.8 | 135 | Citations (PDF) |
| 52 | Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation? | 1.8 | 3 | Citations (PDF) |
| 53 | Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation | 3.8 | 114 | Citations (PDF) |
| 54 | CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing | 1.9 | 2,065 | Citations (PDF) |
| 55 | From melanocytes to melanomas | 34.5 | 779 | Citations (PDF) |
| 56 | NTRK3 kinase fusions in Spitz tumours | 3.2 | 151 | Citations (PDF) |
| 57 | Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation | 5.8 | 36 | Citations (PDF) |
| 58 | Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity | 3.8 | 74 | Citations (PDF) |
| 59 | InactivatingMUTYHgermline mutations in pediatric patients with high-grade midline gliomas | 0.9 | 28 | Citations (PDF) |
| 60 | The Genetic Evolution of Melanoma | 26.4 | 29 | Citations (PDF) |
| 61 | Congenital uveal melanoma? | 4.1 | 14 | Citations (PDF) |
| 62 | Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X | 3.8 | 108 | Citations (PDF) |
| 63 | Biology of advanced uveal melanoma and next steps for clinical therapeutics | 1.9 | 89 | Citations (PDF) |
| 64 | Clinical, Histopathologic, and Genomic Features of Spitz Tumors With ALK Fusions | 2.3 | 151 | Citations (PDF) |
| 65 | Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion | 1.9 | 84 | Citations (PDF) |
| 66 | Activating MET kinase rearrangements in melanoma and Spitz tumours | 10.8 | 158 | Citations (PDF) |
| 67 | Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition | 4.5 | 144 | Citations (PDF) |
| 68 | Genomic Classification of Cutaneous MelanomaCell, 2015, 161, 1681-1696 | 23.4 | 3,076 | Citations (PDF) |
| 69 | A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity | 10.8 | 70 | Citations (PDF) |
| 70 | Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway | 14.1 | 264 | Citations (PDF) |
| 71 | Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination | 5.2 | 173 | Citations (PDF) |
| 72 | The Genetic Evolution of Melanoma from Precursor Lesions | 26.4 | 1,006 | Citations (PDF) |
| 73 | Kinase fusions are frequent in Spitz tumours and spitzoid melanomas | 10.8 | 613 | Citations (PDF) |
| 74 | A Mouse Model Uncovers LKB1 as an UVB-Induced DNA Damage Sensor Mediating CDKN1A (p21WAF1/CIP1) Degradation | 2.2 | 47 | Citations (PDF) |
| 75 | Regulatory network decoded from epigenomes of surface ectoderm-derived cell types | 10.8 | 28 | Citations (PDF) |
| 76 | Ambiguous Melanocytic Tumors With Loss of 3p21 | 2.3 | 81 | Citations (PDF) |
| 77 | Melanoma BRAF Fusions—Letter | 4.5 | 8 | Citations (PDF) |
| 78 | Fluorescence In Situ Hybridization as an Ancillary Tool in the Diagnosis of Ambiguous Melanocytic Neoplasms | 2.3 | 73 | Citations (PDF) |
| 79 | The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia | 20.5 | 468 | Citations (PDF) |
| 80 | In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival | 1.9 | 33 | Citations (PDF) |
| 81 | Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP | 28.4 | 447 | Citations (PDF) |
| 82 | MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells | 5.2 | 35 | Citations (PDF) |
| 83 | Clonal BRAF Mutations in Melanocytic Nevi and Initiating Role of BRAF in Melanocytic Neoplasia | 3.2 | 102 | Citations (PDF) |
| 84 | SOX10 Ablation Arrests Cell Cycle, Induces Senescence, and Suppresses Melanomagenesis | 2.6 | 98 | Citations (PDF) |
| 85 | Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells | 28.4 | 652 | Citations (PDF) |
| 86 | Targeting Activated KIT Signaling for Melanoma Therapy | 12.4 | 17 | Citations (PDF) |
| 87 | Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy | 1.9 | 134 | Citations (PDF) |
| 88 | Skin: Spitz tumors | 0.2 | 0 | Citations (PDF) |
| 89 | A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression | 2.3 | 289 | Citations (PDF) |
| 90 | Sunitinib Therapy for Melanoma Patients with KIT Mutations | 4.5 | 212 | Citations (PDF) |
| 91 | GNA11 (guanine nucleotide binding protein (G protein), alpha 11 (Gq class)) | 0.2 | 0 | Citations (PDF) |
| 92 | GNAQ (guanine nucleotide binding protein (G protein), q polypeptide) | 0.2 | 0 | Citations (PDF) |
| 93 | An unconventional deep penetrating melanocytic nevus with microscopic involvement of regional lymph nodes | 0.7 | 22 | Citations (PDF) |
| 94 | GNAQ and GNA11 mutations in melanocytomas of the central nervous system | 5.8 | 65 | Citations (PDF) |
| 95 | Germline mutations in BAP1 predispose to melanocytic tumors | 14.1 | 739 | Citations (PDF) |
| 96 | BRAF
mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site | 1.9 | 198 | Citations (PDF) |
| 97 | The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin | 1.9 | 245 | Citations (PDF) |
| 98 | Metastatic Melanoma With Striking Adenocarcinomatous Differentiation Illustrating Phenotypic Plasticity in Melanoma | 2.3 | 26 | Citations (PDF) |
| 99 | Assessment of Copy Number Status of Chromosomes 6 and 11 by FISH Provides Independent Prognostic Information in Primary Melanoma | 2.3 | 62 | Citations (PDF) |
| 100 | Molecular-Microscopical Correlation in Dermatopathology | 0.7 | 12 | Citations (PDF) |
| 101 | An isolated Merkel cell carcinoma metastasis at a distant cutaneous site presenting as a second ‘primary’ tumor | 0.7 | 16 | Citations (PDF) |
| 102 | KIT as a Therapeutic Target in Metastatic Melanoma | 14.4 | 835 | Citations (PDF) |
| 103 | Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma | 2.3 | 89 | Citations (PDF) |
| 104 | Mutation-driven drug development in melanoma | 1.3 | 94 | Citations (PDF) |
| 105 | Germline Variation Controls the Architecture of Somatic Alterations in Tumors | 2.2 | 36 | Citations (PDF) |
| 106 | Comment on “Cutaneous Melanoma in Childhood and Adolescence Shows Frequent Loss of INK4A and Gain of KIT” | 1.5 | 1 | Citations (PDF) |
| 107 | Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis | 2.2 | 71 | Citations (PDF) |
| 108 | Somatic Mutation of Epidermal Growth Factor Receptor in a Small Subset of Cutaneous Squamous Cell Carcinoma | 1.5 | 28 | Citations (PDF) |
| 109 | Mutations in
GNA11
in Uveal Melanoma | 26.4 | 1,490 | Citations (PDF) |
| 110 | Genetic and morphologic features for melanoma classification | 1.9 | 139 | Citations (PDF) |
| 111 | Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients | 4.5 | 14 | Citations (PDF) |
| 112 | Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma | 2.0 | 120 | Citations (PDF) |
| 113 | The Presence of Polyomavirus in Non-Melanoma Skin Cancer in Organ Transplant Recipients Is Rare | 1.5 | 56 | Citations (PDF) |
| 114 | Absence of Somatic Mutations of NEMO in Keratoacanthoma | 1.5 | 0 | Citations (PDF) |
| 115 | Germline variation of the melanocortin‐1 receptor does not explain shared risk for melanoma and thyroid cancer | 1.8 | 5 | Citations (PDF) |
| 116 | Frequent mutations in the MITF pathway in melanoma | 1.9 | 138 | Citations (PDF) |
| 117 | Genome‐wide associations studies for melanoma and nevi | 1.9 | 25 | Citations (PDF) |
| 118 | Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma | 2.3 | 469 | Citations (PDF) |
| 119 | Distribution and Significance of Occult Intraepidermal Tumor Cells Surrounding Primary Melanoma | 1.5 | 99 | Citations (PDF) |
| 120 | MC1R Variants Increase Risk of Melanomas Harboring BRAF Mutations | 1.5 | 83 | Citations (PDF) |
| 121 | Absence of PDGFRA Mutations in Primary Melanoma | 1.5 | 16 | Citations (PDF) |
| 122 | Dose‐dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation | 1.9 | 213 | Citations (PDF) |
| 123 | Expanding the genetic spectrum of pigmentation | 1.9 | 5 | Citations (PDF) |
| 124 | Lack of somatic alterations of MC1R in primary melanoma | 1.9 | 8 | Citations (PDF) |
| 125 | Frequent p16-Independent Inactivation of p14ARF in Human Melanoma | 3.2 | 104 | Citations (PDF) |
| 126 | Improving Melanoma Classification by Integrating Genetic and Morphologic Features | 4.6 | 349 | Citations (PDF) |
| 127 | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi | 30.7 | 1,613 | Citations (PDF) |
| 128 | β-Catenin induces immortalization of melanocytes by suppressing
p16
INK4a
expression and cooperates with N-Ras in melanoma development | 2.8 | 294 | Citations (PDF) |
| 129 | The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer | 3.4 | 456 | Citations (PDF) |
| 130 | Chromosomal aberrations in angioimmunoblastic T‐cell lymphoma and peripheral T‐cell lymphoma unspecified: A matrix‐based CGH approach | 1.7 | 92 | Citations (PDF) |
| 131 | Congenital Melanocytic Nevi Frequently Harbor NRAS Mutations but no BRAF Mutations | 1.5 | 324 | Citations (PDF) |
| 132 | Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas | 2.9 | 13 | Citations (PDF) |
| 133 | Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool | 0.4 | 199 | Citations (PDF) |
| 134 | Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway | 12.6 | 317 | Citations (PDF) |
| 135 | PI3-Kinase Subunits Are Infrequent Somatic Targets in Melanoma | 1.5 | 59 | Citations (PDF) |
| 136 | Somatic Activation of KIT in Distinct Subtypes of Melanoma | 12.4 | 1,574 | Citations (PDF) |
| 137 | Genomic Analysis of Blue Nevi and Related Dermal Melanocytic Proliferations | 2.3 | 98 | Citations (PDF) |
| 138 | Distinct Sets of Genetic Alterations in Melanoma | 26.4 | 2,689 | Citations (PDF) |
| 139 | Coalescing, Nevoid Papules in an Infant—Quiz Case | 1.5 | 3 | Citations (PDF) |
| 140 | Coalescing, Nevoid Papules in an Infant—Diagnosis | 1.5 | 0 | Citations (PDF) |
| 141 | Genomic Analysis of Melanocytic Neoplasia | 1.1 | 12 | Citations (PDF) |
| 142 | Molecular genetics of melanocytic neoplasia: practical applications for diagnosis | 1.4 | 26 | Citations (PDF) |
| 143 | Mechanisms of Cell-Cycle Arrest in Spitz Nevi with Constitutive Activation of the MAP-Kinase Pathway | 2.8 | 100 | Citations (PDF) |
| 144 | Consumption of the Epidermis | 2.3 | 72 | Citations (PDF) |
| 145 | Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer | 5.2 | 123 | Citations (PDF) |
| 146 | Classifying Melanocytic Tumors Based on DNA Copy Number Changes | 2.8 | 466 | Citations (PDF) |
| 147 | Atypical junctional melanocytic proliferations in benign lichenoid keratosis | 1.7 | 34 | Citations (PDF) |
| 148 | Two cases of unusual acral melanocytic tumors: Illustration of molecular cytogenetics as a diagnostic tool | 1.7 | 27 | Citations (PDF) |
| 149 | Determinants of BRAF Mutations in Primary Melanomas | 3.2 | 637 | Citations (PDF) |
| 150 | The Longer Your Telomeres, the Larger Your Nevus? | 0.3 | 13 | Citations (PDF) |
| 151 | A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications | 2.1 | 133 | Citations (PDF) |
| 152 | Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice | 5.2 | 136 | Citations (PDF) |
| 153 | Persistent (Recurrent) Spitz Nevi | 2.3 | 121 | Citations (PDF) |
| 154 | Genetic Changes in Neoplasms Arising in Congenital Melanocytic Nevi | 2.8 | 243 | Citations (PDF) |
| 155 | Genomic Approaches to Skin Cancer Diagnosis | 1.5 | 14 | Citations (PDF) |
| 156 | Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas | 1.5 | 162 | Citations (PDF) |
| 157 | Mutations and Copy Number Increase of HRAS in Spitz Nevi with Distinctive Histopathological Features | 2.8 | 475 | Citations (PDF) |
| 158 | Molecular Cytogenetic Analysis of Spitz Nevi Shows Clear Differences to Melanoma | 1.5 | 325 | Citations (PDF) |
| 159 | Pilomatrixkarzinom in ungewöhnlicher Lokalisation | 1.0 | 19 | Citations (PDF) |
| 160 | Signet-ring cell formation in cutaneous neoplasms☆, ☆☆, ★ | 1.5 | 34 | Citations (PDF) |
| 161 | A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation | 1.7 | 10 | Citations (PDF) |
| 162 | Adult Rhabdomyoma of the Lip | 0.3 | 17 | Citations (PDF) |
| 163 | Eosinophilic Globules in Spitz Nevi: No Evidence for Apoptosis | 0.3 | 26 | Citations (PDF) |
| 164 | Elevated levels of interleukin-8 in blister fluid of bullous pemphigoidcompared with suction blisters of healthy control subjects | 1.5 | 43 | Citations (PDF) |
| 165 | Das mikrozystische Adnexkarzinom der Haut Ein unterschätzter Tumor | 1.0 | 12 | Citations (PDF) |
| 166 | Das Riesenzellfibroblastom Ein seltener Weichteiltumor des Kindesalters | 1.0 | 3 | Citations (PDF) |
| 167 | Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid | 0.9 | 91 | Citations (PDF) |
| 168 | Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1α and TNF-α | 0.9 | 9 | Citations (PDF) |
| 169 | Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions 1996, 66, 607-610 | | 100 | Citations (PDF) |
| 170 | Melanoma in childhood: An EORTC-MCG multicenter study on the clinico-pathological aspects 1996, 68, 317-324 | | 96 | Citations (PDF) |
| 171 | Preoperative Characterization of Pigmented Skin Lesions by Epiluminescence Microscopy and High-Frequency Ultrasound | 1.5 | 56 | Citations (PDF) |
| 172 | Autoantibodies to annexins: a diagnostic marker for cutaneous disorders? | 1.8 | 17 | Citations (PDF) |
| 173 | Ist das akrolentigin�se Melanom (ALM) maligner als das superfiziell spreitende Melanom (SSM) in einer High-risk-Lokalisation? | 1.0 | 9 | Citations (PDF) |
| 174 | Prognosevorteil f�r definierte Risikogruppen durch die Lymphknotendissektion | 1.0 | 12 | Citations (PDF) |
| 175 | Der benigne Riesenzelltumor der Sehnenscheide | 1.0 | 2 | Citations (PDF) |
| 176 | Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients | 2.7 | 99 | Citations (PDF) |
| 177 | Localization of annexins in normal and diseased human skin | 1.8 | 26 | Citations (PDF) |
| 178 | WHO
classification of skin tumours: key updates in the fifth edition | 2.6 | 14 | Citations (PDF) |
| 179 | Atypical Lentiginous Melanocytic Proliferations Case Series: Relationship to Type
II
Dysplastic Nevi and Lentiginous Melanoma | 0.7 | 0 | Citations (PDF) |
